A Comprehensive Design-to-skin Pipeline to Fabricate Polymeric Microneedles Using Ultrahigh-resolution 3D Printing

Journal Article (2025)
Author(s)

F. La Malfa (TU Delft - Micro and Nano Engineering)

Isabella A. van Hulst (Leiden University Medical Center)

Ferry Ossendorp (Leiden University Medical Center)

U. Staufer (TU Delft - Micro and Nano Engineering)

Koen van der Maaden (Leiden University Medical Center)

Research Group
Micro and Nano Engineering
DOI related publication
https://doi.org/10.1007/s11095-025-03936-x
More Info
expand_more
Publication Year
2025
Language
English
Research Group
Micro and Nano Engineering
Issue number
11
Volume number
42
Pages (from-to)
2125-2143
Reuse Rights

Other than for strictly personal use, it is not permitted to download, forward or distribute the text or part of it, without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license such as Creative Commons.

Abstract

Objective: Microneedle technologies have emerged as a promising approach to improve intradermal drug delivery. This study presents a comprehensive workflow for fabricating polymeric microneedle arrays utilising ultrahigh-resolution 3-dimensional (3D) printing and silicone mould fabrication. Methods: In this work, an extensive toolbox with over 75 distinct microneedle designs was created and sequentially fabricated from acryl using our workflow based on ultrahigh-resolution 3D printing. Results: The microneedle design parameters included obelisk and cone-like shapes, various lengths, base and tip diameters, and different densities. We systematically assessed the optimal design parameters for effective penetration of ex vivo human skin explants. Conclusion: Our workflow, combined with application in an ex vivo human skin model, allows systematic comparison of multiple microneedle design parameters for efficacy. This work demonstrates the potential of this systematic modelling and ultrahigh-resolution 3D printing approach to optimize microneedles for intradermal biomedical applications, including therapeutic cancer vaccination.